Acute GvHD typically starts with the sudden outbreak of a red, inflamed rash on the palms, soles, face, ears, and shoulders.

1 Rash < 25% Bilirubin 2-2.9 mg/dl Diarrhea ... Acute and chronic graft-versus-host disease (GVHD) remain a major complication of allogneic transplantation. The pathophysiology of GVHD is ...

Gastrointestinal (GI) problems, liver dysfunction, skin rashes, and other symptoms can develop as acute (temporary) GVHD within 100 days of a transplant or as chronic GVHD months — or even years ...

Healthcare professionals determine how to administer steroid therapy based on the severity of GVHD. If symptoms are localized and mild, such as a rash on the skin, topical products might be the ...

Chronic GvHD can be difficult to cope with. It can affect your quality of life. Find out more about how it might affect you and what support is available. The length of time you have chronic GvHD can ...

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the donor's immune cells attack the recipient's tissues. Ocular ...

The FDA has approved Incyte's axatilimab as a treatment for chronic graft-versus-host disease (GvHD), making it a companion to the company's Jakafi for the disorder. The US regulator has cleared ...

The efficacy of IVIG in preventing GvHD has not been definitely demonstrated clinically. Using a xenogeneic model of GvHD in NOD/SCID/γc− (NSG) mice, we showed that weekly administration of ...

Graft versus host disease (GvHD) is a possible complication of a stem cell transplant from another person. GvHD happens when particular types of white blood cells (T cells) in the donated stem cells ...

The regulator has cleared Ryoncil (remestemcel-L) to treat steroid-refractory acute GVHD in paediatric patients aged two months and older. It is derived from MSCs harvested from the bone marrow of ...